|
AU2005201251A1
|
|
Reduction of infarct volume using citicoline
|
|
AU6381000A
|
|
Methods and compositions for alleviating stuttering
|
|
WO9933476A1
|
|
Hyperhydrated citicoline, process and use
|
|
WO9926633A1
|
|
Citicoline to treat motor neuron diseases and demyelinating diseases
|
|
NZ337305A
|
|
Use of citicoline to reduce the extent of infarction subsequent to a ischemic event
|
|
BR9607206A
|
|
Reducing the volume of a heart attack using citicoline
|
|
US5827832A
|
|
Method of protecting brain tissue from cerebral infarction subsequent to ischemia
|
|
US5872108A
|
|
Reduction of infarct volume using citicoline
|
|
US6451523B1
|
|
Detection of a leptin receptor variant and methods for regulating obesity
|
|
US5698525A
|
|
Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
|
|
US5744476A
|
|
Dopamine D1 agonists for the treatment of dementia
|
|
US5403851A
|
|
Substituted tryptamines, phenalkylamines and related compounds
|
|
US5432162A
|
|
Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
|
|
WO9317670A1
|
|
Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
|
|
US5260091A
|
|
Salt taste enhancers
|
|
US5206049A
|
|
Choline-containing compositions as salt substitutes and enhancers and a method of preparation
|
|
IE920448A1
|
|
Novel choline-containing compositions as salt substitutes¹and enhancers
|
|
US5096712A
|
|
Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety
|
|
US5019594A
|
|
Method for decreasing appetite
|
|
US5206218A
|
|
Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
|
